Send to

Choose Destination
J Thorac Dis. 2012 Apr 1;4(2):219-20. doi: 10.3978/j.issn.2072-1439.2012.03.03.

EURTAC first-line phase III randomized study in advanced non-small cell lung cancer: Erlotinib works also in European population.

Author information

Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.

Supplemental Content

Full text links

Icon for AME Publishing Company Icon for PubMed Central
Loading ...
Support Center